Thierry WURCH is SVP of Integrated Biologics Discovery at Evotec, with over 20 years of expertise in biotechnology and oncology. A specialist in therapeutic antibody discovery, he has held strategic positions at Ipsen, Servier, and Pierre Fabre. He also serves as Chair of the NC-IUPHAR Committee for Antibodies and is a member of the editorial board of the journal MABS. His commitment to innovation has earned him recognition as a key player in the field.